National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
Chicago Style (17th ed.) CitationNational Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, and Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
MLA (9th ed.) CitationNational Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, and Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.